163
Views
4
CrossRef citations to date
0
Altmetric
Research Article

High potential to reverse the inhibition of myeloperoxidase by ceruloplasmin of anti-myeloperoxidase autoantibodies of IgG3 subclass

, &
Pages 218-225 | Received 23 Mar 2011, Accepted 10 Jun 2011, Published online: 30 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Catriona A. Walls, Neil Basu, Gayle Hutcheon, Lars P. Erwig, Mark A. Little & Dana Kidder. (2020) A novel 4-dimensional live-cell imaging system to study leukocyte-endothelial dynamics in ANCA-associated vasculitis. Autoimmunity 53:3, pages 148-155.
Read now

Articles from other publishers (3)

Alexey V. Sokolov, Elena T. Zakahrova, Valeria A. Kostevich, Valeria R. Samygina & Vadim B. Vasilyev. (2014) Lactoferrin, myeloperoxidase, and ceruloplasmin: complementary gearwheels cranking physiological and pathological processes. BioMetals 27:5, pages 815-828.
Crossref
J. Land, A. Rutgers & C. G. M. Kallenberg. (2014) Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody. Nephrology Dialysis Transplantation 29:4, pages 739-745.
Crossref
Peng-cheng Xu, Min Chen & Ming-hui Zhao. (2012) Antineutrophil cytoplasmic autoantibody-associated vasculitis in Chinese patients. Clinical and Experimental Nephrology 17:5, pages 705-707.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.